In the event of a non-identified mutation or variant of uncertain significance being detected, metabolite and thymidine phosphorylase activity testing should be performed to confirm or exclude a diagnosis of MNGIE[10]. The gene discussed is TYMP; the disease is mitochondrial neurogastrointestinal encephalomyopathy.